156 related articles for article (PubMed ID: 31309559)
1. Screening high risk populations for cancer: Hepatobiliary.
Bailey A; Shah SA
J Surg Oncol; 2019 Oct; 120(5):847-850. PubMed ID: 31309559
[TBL] [Abstract][Full Text] [Related]
2. Screening for hepatocellular carcinoma in high-risk populations.
Miller ZA; Lee KS
Clin Imaging; 2016; 40(2):311-4. PubMed ID: 26898986
[TBL] [Abstract][Full Text] [Related]
3. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.
Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W
Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for hepatocellular carcinoma.
Sherman M
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
[TBL] [Abstract][Full Text] [Related]
5. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
[TBL] [Abstract][Full Text] [Related]
6. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
Miller G; Schwartz LH; D'Angelica M
Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal cancer in the elderly.
Wallach CB; Kurtz RC
Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
[TBL] [Abstract][Full Text] [Related]
8. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
Rivenbark AG; Coleman WB
Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
[No Abstract] [Full Text] [Related]
9. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.
Hemminki K; Li X
Gut; 2003 Apr; 52(4):592-6. PubMed ID: 12631675
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary cancers in South America: disparity strikes.
Debes JD; Boonstra A; Balderramo D; Mattos AZ; Arrese M;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):581. PubMed ID: 31292069
[No Abstract] [Full Text] [Related]
11. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.
Pulte D; Weberpals J; Schröder CC; Emrich K; Holleczek B; Katalinic A; Luttmann S; Sirri E; Jansen L; Brenner H;
Int J Cancer; 2018 Jul; 143(2):324-332. PubMed ID: 29479701
[TBL] [Abstract][Full Text] [Related]
13. Strengthening the Fight Against HCC.
Berlin J
Tex Med; 2016 Mar; 112(3):53-8. PubMed ID: 26928819
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
Okuda K; Tsuchiya Y; Saisho H
Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
[No Abstract] [Full Text] [Related]
15. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
17. How can we boost colorectal and hepatocellular cancer screening among underserved populations?
Goebel M; Singal AG; Nodora J; Castañeda SF; Martinez E; Doubeni C; Laiyemo A; Gupta S
Curr Gastroenterol Rep; 2015 Jun; 17(6):22. PubMed ID: 26031831
[TBL] [Abstract][Full Text] [Related]
18. Molecular genomic landscapes of hepatobiliary cancer.
Shibata T; Arai Y; Totoki Y
Cancer Sci; 2018 May; 109(5):1282-1291. PubMed ID: 29573058
[TBL] [Abstract][Full Text] [Related]
19. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
McNamara MG
Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
[No Abstract] [Full Text] [Related]
20. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Trinchet JC; Nahon P; Ganne-Carrie N
Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
